Published July 30, 2018
| Version v1
Report
Open
Checking Disruption of Proteins of Interest with Overexpression of HTT
Description
Western blot of RMe2s, RMe2a, Lamin B1, PCNT and coilin in HEK293T cells with HTT Overexpression
Funding acknowledgement: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
Files
(2.6 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:be9ae7a91395065410fc6a1fdaa63133
|
28.8 kB | Download |
|
md5:ef5e9af01706a5d0c3386fdf844661e0
|
2.4 MB | Download |
|
md5:028c6726dd7fabc87fa73f35cfa65b00
|
161.3 kB | Download |